Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05509_nanopub.RAQQuiQ1t_twKtrh-oRfwJMS1cm36mAfK3F8yVApq34S0#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05509 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05509 label "LI-301 [drugbank:DB05509]" assertion.
- drugbank:DB05509 seeAlso DB05509 assertion.
- drugbank:DB05509 description "LI 301 is an orally bio-available compound delivered in a fast melt mechanism with taste masking enabling it to be taken anytime without water. It has a novel mode of action combining both the light effect of a Selective Serotonin Reuptake Inhibitor ("SSRI")(most likely antagonistic at 5HT1a receptors) and antagonism at mu-opioid receptors. This results in a slight dulling of sensation that can be used to treat premature ejaculation without interfering with normal sexual pleasure or orgasm." assertion.
- drugbank:DB05509 identifier "drugbank:DB05509" assertion.
- drugbank:DB05509 title "LI-301" assertion.
- drugbank:DB05509 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05509 drugbank_vocabulary:drugbank-id "DB05509" assertion.
- drugbank:DB05509 bio2rdf_vocabulary:x-identifiers.org DB05509 assertion.
- drugbank:DB05509 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05509" assertion.
- drugbank:DB05509 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05509 bio2rdf_vocabulary:identifier "DB05509" assertion.